Literature DB >> 27056118

The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation.

Tadashi Miyazaki1, Azeem Latib, Neil Ruparelia, Hiroyoshi Kawamoto, Katsumasa Sato, Filippo Figini, Antonio Colombo.   

Abstract

AIMS: Meticulous lesion preparation prior to bioresorbable vascular scaffold (BVS) implantation has been strongly recommended. The aim of this study was to investigate if there was a benefit associated with scoring balloon use in lesion preparation in comparison to conventional balloons prior to implantation of a BVS. METHODS AND
RESULTS: Of the lesions treated with BVS between May 2012 and July 2014, 155 lesions in the conventional balloon group and 29 lesions in the scoring balloon group were included. Procedures without predilatation and those which utilised cutting balloon or rotational atherectomy devices were excluded. Complex (B2/C lesion: 76.1% vs. 93.1%; p=0.028), restenotic (5.2% vs. 17.2%; p=0.036) and calcified (36.1% vs. 79.3%; p<0.001) lesions were more common in the scoring balloon group. Compared to the conventional balloon group, the scoring balloon group demonstrated better procedural IVUS outcomes with regard to both expansion index (defined as scaffold lumen area divided by final post-dilatation balloon cross-sectional area, 0.71 vs. 0.86; p<0.001) and eccentricity index (defined as minimal scaffold diameter divided by maximal scaffold diameter, 0.78 vs. 0.84; p<0.001). The occurrence of ischaemia-driven target lesion revascularisation at one year was similar (6.1% vs. 7.1%; p=0.87).
CONCLUSIONS: Lesion preparation for complex lesions using a scoring balloon appeared to facilitate optimal sizing and radially concentric expansion of BVS.

Entities:  

Mesh:

Year:  2016        PMID: 27056118     DOI: 10.4244/EIJV11I14A308

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.

Authors:  Takao Sato; John Jose; Mohamed El-Mawardy; Dmitriy S Sulimov; Ralph Tölg; Gert Richardt; Mohamed Abdel-Wahab
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-19       Impact factor: 2.357

Review 2.  Bioresorbable vascular scaffolds - basic concepts and clinical outcome.

Authors:  Ciro Indolfi; Salvatore De Rosa; Antonio Colombo
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

Review 3.  Bioresorbable Vascular Scaffold Korean Expert Panel Report.

Authors:  Jung Min Ahn; Duk Woo Park; Sung Jin Hong; Young Keun Ahn; Joo Yong Hahn; Won Jang Kim; Soon Jun Hong; Chang Wook Nam; Do Yoon Kang; Seung Yul Lee; Woo Jung Chun; Jung Ho Heo; Deok Kyu Cho; Jin Won Kim; Sung Ho Her; Sang Wook Kim; Sang Yong Yoo; Myeong Ki Hong; Seung Jea Tahk; Kee Sik Kim; Moo Hyun Kim; Yangsoo Jang; Seung Jung Park
Journal:  Korean Circ J       Date:  2017-11-06       Impact factor: 3.243

Review 4.  Contemporary tools and devices for coronary calcium modification.

Authors:  Heerajnarain Bulluck; Margaret McEntegart
Journal:  JRSM Cardiovasc Dis       Date:  2022-04-05

Review 5.  Bioresorbable Scaffolds: Contemporary Status and Future Directions.

Authors:  Xiang Peng; Wenbo Qu; Ying Jia; Yani Wang; Bo Yu; Jinwei Tian
Journal:  Front Cardiovasc Med       Date:  2020-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.